LCM
AKBA icon

Landscape Capital Management’s Akebia Therapeutics AKBA Stock Holding History

Landscape Capital Management’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-40,035
Closed -$221K – 661
2018
Q4 		$221K Buy
+40,035
New +$313K 0.02% 744
2018
Q3 		– Sell
-72,879
Closed -$727K – 691
2018
Q2 		$727K Sell
72,879
-43,537
-37% -$436K 0.06% 234
2018
Q1 		$1.11M Buy
116,416
+82,315
+241% +$1.15M 0.08% 207
2017
Q4 		$507K Buy
34,101
+19,755
+138% +$328K 0.05% 389
2017
Q3 		$282K Sell
14,346
-11,717
-45% -$180K 0.03% 401
2017
Q2 		$375K Buy
26,063
+4,109
+19% +$52.1K 0.04% 229
2017
Q1 		$202K Buy
21,954
+4,454
+25% +$43.5K 0.02% 442
2016
Q4 		$182K Hold
17,500
– – 0.02% 486
2016
Q3 		$158K Sell
17,500
-104,826
-86% -$891K 0.02% 395
2016
Q2 		$915K Sell
122,326
-2,675
-2% -$23.4K 0.12% 195
2016
Q1 		$1.13M Buy
125,001
+83,601
+202% +$678K 0.14% 217
2015
Q4 		$535K Buy
+41,400
New +$422K 0.07% 434

Other funds holding AKBA

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Landscape Capital Management's AKBA Position: Q1 2019 in Review

Landscape Capital Management sold out of Akebia Therapeutics (AKBA) in Q1 2019, closing a stake of 40,035 shares — an estimated $221K sold.

Landscape Capital Management first reported a position in AKBA in Q4 2015 and held it in 12 quarters. The position peaked at $1.13M in Q1 2016. 169 funds tracked by Wall St. Rank hold AKBA as of Q1 2019.

  • Landscape Capital Management reported no remaining Akebia Therapeutics position as of Q1 2019 after selling out during the quarter.
  • Landscape Capital Management sold 40,035 Akebia Therapeutics shares in Q1 2019, an estimated $221K.
  • Landscape Capital Management first reported a position in Akebia Therapeutics in Q4 2015 and held it in 12 quarters.
  • Landscape Capital Management's Akebia Therapeutics position peaked at $1.13M in Q1 2016.
  • 169 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q1 2019.

Based on Landscape Capital Management's 13F filing for Q1 2019, filed 15 May 2019.